Biodesix (BDSX) Upgraded by Zacks Investment Research to Hold

Biodesix} stock has undergone multiple analysts rating changes in the recent past.  Biodesix Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Biodesix (BDSX) Upgraded by Zacks Investment Research to Hold